Camille L. Bedrosian
Chief Medical Officer at Amylyx Pharmaceuticals · 8 reported transactions in 3 companies · latest trade Sep 10, 2026
Their trades
Sold | Sep 10, 2026 | Sep 10, 2026 close $32.09 → Oct 29, 2026 close $28.68. S&P 500 +1.9% over the same days. | ||
Sold | Sep 10, 2026 | Sep 10, 2026 close $32.09 → Oct 29, 2026 close $28.68. S&P 500 +1.9% over the same days. | ||
Sold | Dec 1, 2025 | Dec 1, 2025 close $14.24 → Oct 29, 2026 close $28.68. S&P 500 +13.5% over the same days. | ||
Sold | Sep 30, 2025 | Sep 30, 2025 close $13.59 → Oct 29, 2026 close $28.68. S&P 500 +15.9% over the same days. |
$68.9K
Sep 10, 2026 close $32.09 → Oct 29, 2026 close $28.68. S&P 500 +1.9% over the same days.
$256K
Sep 10, 2026 close $32.09 → Oct 29, 2026 close $28.68. S&P 500 +1.9% over the same days.
$94.4K
Dec 1, 2025 close $14.24 → Oct 29, 2026 close $28.68. S&P 500 +13.5% over the same days.
$175.5K
Sep 30, 2025 close $13.59 → Oct 29, 2026 close $28.68. S&P 500 +15.9% over the same days.